Cristine Klatt-Cromwell, MD
Otolaryngology · Saint Louis, MONPI 1407147150
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,550 of the $13,445 with a category attached, or 63.6%. Intersect ENT, Inc. accounts for 76.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $9,647 and has fallen 99.7% since, to $33 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $320.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$10K
- Medtronic$2K
- Acclarent, Inc$694
- KARL Storz Endoscopy-america$85
- Regeneron$33
- Olympus America Inc.$18
Across 3 payments — averaging $7210.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$22K
What the payments were for
- Consulting fees$2,16016%
- Speaking & faculty fees$8,55064%
- Travel & lodging$9107%
- Food & beverage$1,82514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 16 | $10,219 |
| Medtronic(2 entities) | 15 | $2,396 |
| Acclarent, Inc | 7 | $694 |
| KARL Storz Endoscopy-america | 2 | $85 |
| Regeneron | 1 | $33 |
| Olympus America Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,445 in reported general payments places this provider in the 95th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 12 | $2,679 |
| Ipratropium Bromide | 59 | $2,419 |
| Azelastine Hcl | 20 | $808 |
| Fluticasone Propionate | 52 | $581 |
| Mupirocin | 27 | $220 |
| Doxycycline Hyclate | 11 | $97 |
| Omeprazole | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Saint Louis
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Lauren RolandSaint Louis$11K
- James HartmanSaint Louis$7K
- Robert ObertSaint Louis$7K
- Barry RosenblumSaint Louis$4K
- Arya NaminSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.